The increased prevalence of pigmentation disorders is anticipated to open up new avenues for the pigmentation disorders treatment market

Pigmentation disorders occur due to the abnormal production of melanin in the skin that gives varied skin color. The products available in the pigmentation disorders treatment market include creams, lasers, chemical peels, and microdermabrasion that help reduce the severity of pigmentation. Some common pigmentation disorders treated are melasma, vitiligo, freckles, age spots, and post-inflammatory hyperpigmentation.

Market Dynamics:
There are two major drivers that are fueling growth of the pigmentation disorders treatment market. Firstly, the increasing prevalence of pigmentation disorders globally due to rising pollution levels and exposure to sun is creating high demand for pigmentation disorders treatments. Secondly, the introduction of new drugs and devices for pigmentation treatments is driving the market growth. Some key innovations include combination therapy drugs, microneedling, intense pulsed light therapy, and fractional laser resurfacing treatments.

Segment Analysis
The global pigmentation disorders treatment market is dominated by the topical drugs segment owing to its effectiveness and convenience of use. This segment currently holds over 60% value share of the overall market and is expected to remain dominant during the forecast period. Topical drugs are prescribed to be applied on the affected areas of the skin to treat hyperpigmentation disorders like melasma and post-inflammatory hyperpigmentation. Some of the commonly prescribed topical drugs include hydroquinone, azelaic acid, kojic acid, arbutin, and mercury.

PEST Analysis
Political: Regulations related to the sale and marketing approval of drugs and medications for pigmentation disorders vary across countries. Stringent regulations may delay drugs launches.
Economic: Rising disposable incomes in developing nations have increased healthcare spending on aesthetic procedures, fueling market growth. However, higher drug costs can limit widespread adoption.
Social: Growing social acceptability of aesthetic procedures and desire to look visually appealing is a key driver. However, side effects and risks of hydroquinone use have shifted preferences to herbal alternatives.
Technological: Adoption of advanced drug delivery systems like nanoemulsions, liposomes, and microspheres help increase efficacy and comfort of topical medications.

Key Takeaways
The global pigmentation disorders treatment market is expected to witness high growth, exhibiting CAGR of 6.0% over the forecast period, due to increasing preference for topical medications over oral drugs and laser treatments.

The Asia Pacific region is expected to witness the fastest growth during the forecast period. Rising disposable incomes, growing social acceptability of aesthetic treatments, and increasing influence of western beauty ideals are driving market growth in the region.

Key players operating in the pigmentation disorders treatment market are Abbvie Inc. (Allergan Inc.), Episciences Inc., L'ORÉAL SA (SkinCeuticals International), and Pfizer Inc., among others. Major players are focusing on expanding their product portfolios through acquisitions and new product launches. For instance, in 2022, SkinCeuticals launched a new topical serum to reduce pigmentation.

Read More:

https://www.marketwebjournal.com/pigmentation-disorders-treatment-market-demand-share-analysis/ 

Comments

Popular posts from this blog

The Notchback Market is Estimated To Witness High Growth Owing To Rising Demand From Emerging Economies

The increasing demand for adhesives and sealants is anticipated to open up the new avenue for Petroleum Resins Market

Global Synthetic Biology Market Analysis: Size and Share